Investigating the Use of Regorafenib (Stivarga) in Patients With Metastatic Colorectal Cancer (mCRC) After Failure of Standard Therapy

The purpose of the study is to investigate the safety and effectiveness of Stivarga in patients with metastatic colorectal carcinoma in routine use in Germany. The study is purely observational, only data from routine treatment are to be collected. The treatment and treatment conditions are solely at discretion of the treating physician.

本研究旨在调查德国临床常规应用场景下，瑞戈非尼（Stivarga）用于转移性结直肠癌患者的安全性与有效性。本研究为纯观察性研究，仅收集常规治疗相关数据；治疗方案及治疗条件完全由经治医师自主决定。